Advantages of Sequential or Bracketed Injection Methods to Improve the Chromatographic Analysis of Biotherapeutics
简介:
- 作者: Szabolcs Fekete, Mateusz Imiołek, Matthew Lauber
- 杂志: LCGC International
- 出版日期: 2024 Jul 3
论文中使用的产品/服务
Quotation shows PackGene:The Fluc mRNA/LNP was purchased from PackGene Biotech – Cap 1+N1meψUTP+LNP (Firefly Luciferase-mRNA-SM-102).
Research Field:Chromatographic Analysis of Biotherapeutics
摘要
High-performance liquid chromatography (HPLC) analysis of biotherapeutics introduces new challenges because large molecules may require distinct injection modes or sample handling protocols to improve the analysis. Some challenges can be addressed by using autosampler methods that allow an analyst to program specific injection sequences. This article explores three case studies where autosampler injection programs help to (i) reduce the carry-over observed for large nucleic acids during anion-exchange chromatography (AEX), (ii) reduce peak distortion and breakthrough for monoclonal antibodies (mAbs) during hydrophilic-interaction chromatography (HILIC), and (iii) facilitate dissolution of lipid nanoparticles (LNPs) so that a size-exclusion chromatography (SEC) method can be applied for ribonucleic acid (RNA) payload analysis. The appropriate use of autosampler capabilities offers unique benefits to analyze biotherapeutics.
关于派真
作为一家专注于AAV 技术十余年,深耕基因治疗领域的CRO&CDMO,派真生物可提供从载体设计、构建到 AAV、慢病毒和 mRNA 服务的一站式解决方案。凭借深厚的技术实力、卓越的运营管理和高标准的服务交付,我们为全球客户提供一站式CMC解决方案,包括从早期概念验证、成药性评估到IIT、IND及BLA的各个阶段。
凭借我们独立知识产权的π-alphaTM 293 细胞AAV高产技术平台,我们能将AAV产量提高多至10倍,每批次产量可达1×10¹⁷vg,以满足多样化的商业化和临床项目需求。此外,我们定制化的mRNA和脂质纳米颗粒(LNP)产品及服务覆盖药物和疫苗开发的各个阶段,从研发到符合GMP的生产,提供端到端的一站式解决方案。